Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LTA4H | P09960 | 3/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.33 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.33 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL9287277 | 0.90 | CA4 (0.40) | TSHRLTA4HCA4KCNA3ALDH1A1 | |
| SCHEMBL53548 | 0.82 | TSHR (0.45) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL10503197 | 0.80 | TSHR (0.43) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL7032868 | 0.78 | CA4 (0.43) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL8993692 | 0.78 | TSHR (0.41) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL4532633 | 0.78 | ALDH1A1 (0.43) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL11081791 | 0.78 | MAOA (0.42) | TSHRLTA4HCA4KCNA3MAOA | |
| SCHEMBL6003069 | 0.78 | LTA4H (0.41) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL10489117 | 0.78 | LTA4H (0.41) | TSHRLTA4HCA4KCNA3CA5A | |
| SCHEMBL29071119 | 0.76 | TSHR (0.48) | TSHRLTA4HCA4KCNA3CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0294686-B1 | PROCESS FOR THE PREPARATION OF DIARYLIMINOCARBONATES | BASF Aktiengesellschaft (DE) | 1992-12-09 | — | — | EP | claimed |
| US-20260069549-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4186888-B1 | COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250228777-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2025-07-17 | — | — | US | disclosed |
| US-12324859-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | MODERNATX, INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-12263248-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | MODERNATX, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| CN-113382767-B | Urea compounds having substituents | 第一三共株式会社 | 2024-12-24 | — | — | CN | disclosed |
| US-12083108-B2 | Compounds for targeting mutant huntingtin protein and uses thereof | CHDI FOUNDATION, INC. (US) | 2024-09-10 | — | — | US | disclosed |
| US-11981686-B2 | Urea compound having substituent | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-05-14 | — | — | US | disclosed |
| EP-4186888-A1 | COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ModernaTX, Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| US-4851550-A | Process for the preparation of cyclic aliphatic orthocarbonic esters new cyclic orthocarbonic esters | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | disclosed |
| EP-0294686-A2 | Process for the preparation of diaryliminocarbonates | BASF Aktiengesellschaft (DE) | 1988-12-14 | — | — | EP | disclosed |
| EP-0294686-A2 | Process for the preparation of diaryliminocarbonates | BASF Aktiengesellschaft (DE) | 1988-12-14 | — | — | EP | disclosed |
| EP-0275888-A2 | Tricyclic benzimidazoles, process for their preparation and use as medicaments | Roche Diagnostics GmbH (DE) | 1988-07-27 | — | — | EP | disclosed |
| EP-0190568-A1 | Process for the preparation of spiroorthocarbonates | BAYER AG (DE) | 1986-08-13 | — | — | EP | disclosed |
| EP-0034421-B1 | N-PHENYL-N'-CYANO-0-PHENYLISOUREAS AND PROCESS FOR THEIR PREPARATION | SMITHKLINE BECKMAN CORPORATION (US) | 1983-04-27 | — | — | EP | disclosed |
| EP-0057564-A1 | Process for preparing 3,5-diamino-1,2,4-triazoles | SMITHKLINE BECKMAN CORPORATION (US) | 1982-08-11 | — | — | EP | disclosed |
| US-4321393-A | Method for preparing 2-cyanamidobenzimidazoles or 2-cyanamidobenzoxazoles | SMITHKLINE CORPORATION (US) | 1982-03-23 | — | — | US | disclosed |
| EP-0034421-A2 | N-phenyl-N'-cyano-0-phenylisoureas and process for their preparation | SMITHKLINE BECKMAN CORPORATION (US) | 1981-08-26 | — | — | EP | disclosed |
| US-4285878-A | N-Phenyl-N'-cyano-O-phenylisoureas | SMITHKLINE CORPORATION (US) | 1981-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12324859-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | LNPK, PLTP, PLIN3 | TSHR 3089/4885LTA4H 2990/4885CA4 4516/4885 |
| US-11981686-B2 | Urea compound having substituent | SIRT6, SIRT1, SIRT2 | TSHR 3651/4885LTA4H 2686/4885CA4 4459/4885 |
| US-12083108-B2 | Compounds for targeting mutant huntingtin protein and uses thereof | HTT, HYPK, UBQLN2 | TSHR 3537/4885LTA4H 4514/4885CA4 4826/4885 |
| US-12263248-B2 | Compounds and compositions for intracellular delivery of therapeutic agents | LNPK, PLTP, PLIN3 | TSHR 3089/4885LTA4H 2990/4885CA4 4516/4885 |
| US-20260069549-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | SIN3A, PLIN3, MSR1 | TSHR 540/4885LTA4H 3520/4885CA4 3934/4885 |
| US-20250228777-A1 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | LNPK, PLTP, PLIN3 | TSHR 3089/4885LTA4H 2990/4885CA4 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.